Lv5
1280 积分 2025-12-01 加入
Novel Theranostic Targets for Prostate Cancer Beyond Prostate-Specific Membrane Antigen
1个月前
已关闭
Ivonescimab plus chemotherapy versus tislelizumab plus chemotherapy in advanced squamous non-small-cell lung cancer (HARMONi-6): interim overall survival analysis of a randomised, double-blind, phase 3 trial in China
1个月前
已完结
GRPR‐Targeted Radionuclide Conjugates: A Molecular Evolution Perspective
2个月前
已完结
GRPR Expression in Metastatic Cancers: A Review of Potential Application of GRPR-Radioligand Therapy
2个月前
已完结
[177Lu]Lu-PSMA-617 in patients with PSMA-positive metastatic androgen pathway modulator-naive/sensitive prostate cancer (PSMAddition): a phase 3 randomised, controlled trial
2个月前
已完结
[177Lu]Lu-PSMA-617 in patients with PSMA-positive metastatic androgen pathway modulator-naive/sensitive prostate cancer (PSMAddition): a phase 3 randomised, controlled trial
2个月前
已完结
Dose-intensified PSMA Radioligand Therapy: The Rationale Behind the OPTIMAL-PSMA Trial
2个月前
已完结
Phase 1 Dose-Escalation Study of [ 225 Ac]Ac-PSMA I&T in Patients with Metastatic Castration-Resistant Prostate Cancer: An Analysis of Safety, Tolerability, and Dosimetry
5个月前
已关闭
Diagnostic Performance of FAPI PET in Patients with Breast Cancer: A Systematic Review
5个月前
已完结
皖公网安备34019202002308
